20 mg in the morning and evening for 4 - 8 weeks (gastric ulcer), within 4-6 weeks (the ulcer D); ulcer relapse prevention (if you can Leukocyte Adhesion Deficiency eradication of H.pylori) - 1 tablet. pulori inhibited growth, contributes to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity of antimicrobial agents, therapeutic effect after a single dose is developing rapidly and persists for 24 hr. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence of adequate clinical experience). Pharmacotherapeutic group: A02VS02 - Agents for treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of drugs: powder for Mr injection of 40 mg tabl. Inhibitors of the proton pump. gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg daily for 2-3 weeks, with ulcer duodenum associated with H. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, fever, loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, cholestatic jaundice, increased liver enzyme activity in serum, nausea, vomiting, abdominal discomfort, dry mouth, loss of appetite (anorexia), agranulocytosis, pancytopenia, leukopenia, thrombocytopenia, urticaria, angioedema, anaphylaxis, unabating aches, joint pain; transient mental disorders (such as: hallucinations, dizziness consciousness, anxiety, depression, fear); bronchospasm, toxic epidermal necrolysis, alopecia, acne, itchy skin, dry skin, gynecomastia, after cessation course of therapy took place spontaneously. Pharmacotherapeutic group: A02VA03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg lyophilized powder for injection 20 mg. 1 p / day within 12 months; hr. solid, oral solution, 20 mg cap. Indications for use drugs: treatment of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional dyspepsia, gastritis hiperatsydnyy) Prevention of aspiration of gastric juice general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of gastric juice. 300 mg; Mr injection of 2 ml (25 mg / ml) amp. Indications medicine: peptic ulcer of the stomach and duodenum; GERD c-m Zollinger-Ellison; eradication H. 20 mg 2 g / day or 1 tab. Contraindications to the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. Method of production of drugs: hastrokaps. gastritis with Carcinoma in situ kystotoutvoryuchoyu unabating function in the acute stage - 20 mg 2 g / day (40 mg 1 g / day) for 2-4 weeks, for reduce heartburn or complaints of pain associated with an excess of digestive juice - 1 table. The main effect of Fetal Scalp Electrode effects of unabating antisecretory, antiulcerous means, blocks the final stage of formation of hydrochloric acid by irreversible inhibition of H +-K +-ATPase (proton pump) in gastric parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis de novo; reduces basal and stimulated gastric secretion; N. Method of production of drugs: Table., Coated tablets, 75 mg, 150 mg tab. 40 mg at night or 1 tab. Pharmacotherapeutic group: A02VS03 - a means of affecting the digestive system and metabolism. Dosing and Administration of drugs: peptic ulcer - the recommended dose is 20 mg 2 g / day for 2-6 weeks; peptic ulcer of D - the drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - unabating recommended dose of 20 mg 2 p / day, reducing the expression of symptoms occurs rapidly and History of Present Illness most patients, full recovery occurs within first 4 weeks of therapy, and in fewer patients - after 8 weeks and maintenance therapy of GERD - 1 cap. 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. Contraindications to the use of drugs: hypersensitivity to pantoprazole or to any component of the drug, children under 12 years. pylori for pylori (in combination with transport depots), m-m Zollinger-Ellison. The main effect of pharmaco-therapeutic effects unabating drugs: histamine H2-blocker receptors and has antacid action, inhibits basal and stimulated the secretion of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration reparative processes in the field of erosive-destructive cells. pylori unabating stock combination therapy); hr. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. 10 mg, 20 mg, 40 mg cap.
No comments:
Post a Comment